Spondyloarthropathies

• CLINICAL_TRIALS research · 2025-11-17
  Clinical Trial Update: Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment [NA]

  This clinical trial update indicates recruitment is ongoing for a study examining how intestinal microbiota evolves in juvenile patients wit…

• EMA approval · 2025-03-03
  EMA Authorised: Nepexto (etanercept) — Biosimilar Collaborations Ireland Limited

  EMA authorised Nepexto, a biosimilar of etanercept, developed by Biosimilar Collaborations Ireland Limited, for several inflammatory arthrit…

• CLINICAL_TRIALS trial_result · 2024-11-01
  Clinical Trial Update: Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed with Spondyloarthritis [NA]

  A completed clinical trial evaluated the effects of pain neuroscience education and physiotherapy for spondyloarthropathies, including ankyl…

• CLINICAL_TRIALS trial_result · 2024-05-10
  Clinical Trial Update: Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)

  A completed clinical trial in Sweden evaluated the safety of etoricoxib (MK-0663) in patients with spondyloarthropathies, including ankylosi…

• CLINICAL_TRIALS trial_result · 2017-11-30
  Clinical Trial Update: Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis [Phase 3]

  Phase 3 trial assessing the mechanism of action of an anti-IL-17 therapy in peripheral spondyloarthritis, with the study status reported as …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-05-13
  Clinical Trial Update: Seronegative Oligoarthritis of the Knee Study (SOKS) [Phase 2]

  Phase 2 clinical trial update for the Seronegative Oligoarthritis of the Knee Study (SOKS) indicates the study was terminated. Results were …

• CLINICAL_TRIALS trial_result · 2015-11-17
  Clinical Trial Update: Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF [Phase 4]

  This Phase 4 trial update evaluates a protocol for reducing anti-TNF dosing in patients with spondyloarthropathies who are in clinical remis…

• CLINICAL_TRIALS trial_result · 2013-12-25
  Clinical Trial Update: Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis [Phase 3]

  Phase 3 clinical trial update for certolizumab pegol in active axial spondyloarthritis completed with results posted.

• CLINICAL_TRIALS trial_result · 2009-11-10
  Clinical Trial Update: Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy [Phase 4]

  Phase 4 trial evaluating etanercept for refractory heel enthesitis in spondylarthropathy has completed and results were posted in 2009.

• CLINICAL_TRIALS trial_result · 2007-04-10
  Clinical Trial Update: TNFalfa Blocking Treatment of Spondylarthropathies [Phase 4]

  Phase 4 clinical trial evaluating TNF-alpha blockade for spondyloarthropathies has completed, including ankylosing spondylitis and psoriatic…